People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

13.84USD
3:14pm EDT
Price Change (% chg)

$-0.33 (-2.33%)
Prev Close
$14.17
Open
$14.50
Day's High
$14.50
Day's Low
$13.59
Volume
610,966
Avg. Vol
1,188,771
52-wk High
$15.95
52-wk Low
$8.95

Search Stocks

Ebersman, David 

Brief Biography

Mr. David A. Ebersman is an Independent Director of Ironwood Pharmaceuticals, Inc., since July 2009. Mr. Ebersman is currently chief financial officer of Facebook, Inc. Prior to joining Facebook, he held a number of positions at Genentech, Inc., until its acquisition by Hoffmann-La Roche in March 2009. At Genentech, he was appointed executive vice president in January 2006 and chief financial officer in March 2005. Previously, he served as senior vice president, finance from January 2005 through March 2005 and senior vice president, product operations from May 2001 through January 2005. He joined Genentech in February 1994 as a business development analyst and subsequently served as manager, business development from February 1995 to February 1996, director, business development from February 1996 to March 1998, senior director, product development from March 1998 to February 1999 and vice president, product development from February 1999 to May 2001. Prior to joining Genentech, Mr. Ebersman held the position of research analyst at Oppenheimer & Company, Inc. Mr. Ebersman was selected as a Fellow in the Henry Crown Fellowship Program. Mr. Ebersman received an A.B. in economics and international relations from Brown University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bryan Roberts

--

Peter Hecht

2,410,130

Michael Higgins

1,007,600

Thomas Graney

--

Mark Currie

1,702,650

Thomas McCourt

1,131,320
As Of 30 Dec 2013
Search Stocks